Krüppel-like factor 4 (Klf4) is a novel regulator of neonatal lung fibroblast homeostasis and reduced in hyperoxia-induced lung injury

D. Hirani (Köln, Germany), M. Koch (Köln, Germany), K. Dinger (Köln, Germany), J. Mohr (Köln, Germany), C. Vohlen (Köln, Germany), C. Klaudt (Köln, Germany), J. Dötsch (Köln, Germany), M. Alejandre Alcazar (Köln, Germany)

Source: International Congress 2018 – Molecular and cellular determinants of the developing lung
Session: Molecular and cellular determinants of the developing lung
Session type: Thematic Poster
Number: 1379
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Hirani (Köln, Germany), M. Koch (Köln, Germany), K. Dinger (Köln, Germany), J. Mohr (Köln, Germany), C. Vohlen (Köln, Germany), C. Klaudt (Köln, Germany), J. Dötsch (Köln, Germany), M. Alejandre Alcazar (Köln, Germany). Krüppel-like factor 4 (Klf4) is a novel regulator of neonatal lung fibroblast homeostasis and reduced in hyperoxia-induced lung injury. 1379

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Krüppel-like Factor 4 is a Stat3-Smad2 regulator in ATII cells determining ATII cell fate during lung development and hyperoxia-induced lung injury
Source: International Congress 2019 – Molecular and experimental paediatric lung disease
Year: 2019



Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008

Electroporation-mediated HGF gene transfer increases mesenchymal stem cell and decreases MMP24 levels in a bleomycin-induced lung injury model.
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

Potential involvement of Egr1 (early growth response 1) gene in mediation of alveolarization and lung growth
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007


Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003

Vascular endothelial growth factor (VEGF) mRNA isoforms in an animal model of acute lung injury
Source: Annual Congress 2003 - Animal models of lung injury: useful or not?
Year: 2003


Bone morphogenetic protein 9 protects against neonatal hyperoxia-induced impairment of lung development, inflammation and fibrosis.
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017

Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction
Source: Eur Respir J 2012; 40: 424-435
Year: 2012



Keratinocyte growth factor (rHuKGF) increases surfactant protein A in rats and prevents alveolar oedema after orthotopic rat lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 779s
Year: 2006

The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in lung fibroblast response to TGF-β and pulmonary fibrogenesis
Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Year: 2017



YI01 - Follistatin-like 1: a crucial factor in lung development and a novel regulator of airway remodelling
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012

Haemophilus influenzae (NTHi) up-regulates acute inflammation in human lung tissue and causes downregulation of transforming growth factor-beta (TGF-beta) – A possible role of NTHi in remodeling processes in human lung tissue
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010

Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury
Source: Eur Respir J, 59 (1) 2004216; 10.1183/13993003.04216-2020
Year: 2022



miR-184 mediates hyperoxia-induced injury by targeting cell death and angiogenesis signalling pathways in the developing lung
Source: Eur Respir J, 58 (3) 1901789; 10.1183/13993003.01789-2019
Year: 2021



Decreased VEGF concentration in lung tissue and vascular injury during ARDS
Source: Eur Respir J 2005; 25: 139-146
Year: 2005



Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma
Source: Eur Respir J 2011; 38: 679-687
Year: 2011



Follistatin-like 1 promotes intermittent hypoxia-induced lung fibroblast activation in vitro and in vivo
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012

ATF3 is activated in ventilator induced lung injury (VILI)
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008

Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung
Source: Eur Respir J 2006; 28: Suppl. 50, 822s
Year: 2006